Neonatal Infant Care Global Market Report 2023 – By Product Type (Thermoregulation Devices, Phototherapy Devices, Monitoring Systems, Neonatal Hearing Screening, Neonatal Infant Resuscitator Devices, Vision Screening, Others Products), By Prenatal and Fetal Equipment (Ultrasound and Ultrasonography Devices, Fetal Doppler's, Fetal Magnetic Resonance Imaging (MRI), Fetal Monitors), By Neonatal Equipment (Infant Warmers and Incubators, Phototherapy Equipment, Neonatal Monitoring Devices and Respiratory Assistance, Monitoring Devices), By End-User (Hospitals, Nursing Homes, Pediatric and Neonatal Clinics) – Market Size, Trends, And Global Forecast 2023-2032

The infant formula ingredients refer to the infant formula product based on a cow, any other animal milk, or a combination thereof, which is suitable for infant feeding. This formula sources a replacement for the women's breast milk with the nutrients available in the cow's milk, soymilk, and protein hydrolysates form. The infant formula ingredients are combined with the essential vitamins, minerals, oils & fats, and all required ingredients necessary for the infants. The main types of infant formula ingredients are carbohydrates, oil & fats, protein, vitamin, minerals, prebiotics. Carbohydrate is an ingredient used in infant formula. The forms of infant formula ingredients are powder, liquid, semi liquid. Infant formula ingredients are used in growing milk, standard infant, follow on formula, specialty formula. The global infant formula ingredients market is segmented - 1) By Ingredients Type: Carbohydrates, Oil And Fats, Protein, Vitamin, Minerals, Prebiotics 2)By Form: Powder, Liquid, Semi Liquid 3)By Application: Growing Milk, Standard Infant, Follow On Formula, Specialty Formula The global infant formula ingredients market size grew from $19.77 billion in 2022 to $21.56 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of the global infant formula ingredients is expected to grow to $30.13 billion in 2027 at a CAGR of 8.7%. The growing focus on infant care and nutrition is expected to drive the infant formula ingredients market. The focus on infant care and nutrition is growing due to the need for lowering morbidity and mortality, reducing the risk of chronic disease throughout their life span, and promoting regular mental and physical development. This growing focus on infant care and nutrition will create a significant demand for infant formula ingredients as these are an effective alternative to breast milk and provide sufficient nutrition to infants. During infancy and early childhood, adequate nutrition by way of infant formula ingredients ensures children's total growth, health, and development as well as promotes healthy growth and cognitive development in infants. Infant formula ingredients also lower the chances of becoming overweight or obese and developing non-communicable diseases (NCDs) later in life. For instance, according to the key facts published in June 2021 by the World Health Organization (WHO), undernutrition is projected to be associated with 2.7 million child deaths, or 45% of all child deaths annually. More than 820,000 children's lives can be saved every year among children under 5 years if all children 0–23 months are breastfed sufficiently. Only a few children receive nutritionally adequate and safe complementary foods and, in many countries, less than a fourth of infants 6–23 months of age meet the criteria of dietary diversity and feeding frequency that are appropriate for their age. This indicates that the focus is growing on infant care and nutrition. In response to this, WHO has been supporting countries with the implementation and monitoring of the "comprehensive implementation plan on maternal, infant and young child nutrition". Therefore, the growing focus on infant care and nutrition will drive the infant formula ingredients market. Major players in the infant formula ingredients market are Arla Foods amba, Fonterra Co-Operative Group Limited, Royal FrieslandCampina NV, Dupont, Sachsenmilch Leppersdorf GmbH, Chr. Hansen Holding A/S, Carbery Food Ingredients Limited, Glanbia plc, Abbott Laboratories, Danone SA, Meiji Holdings Co. Ltd., Nestle, Synutra International Inc., The Kraft Heinz Company and Watson Inc. Rising demand for organic infant formula is a key trend gaining popularity in the infant formula ingredients market. Organic infant formula is a non-GMO (non-genetically modified) product made from grass-fed cows and has no artificial growth hormones or antibiotics. The popularity of organic infant formula is increasing because of its multiple benefits such as low/no health complications. There is a segment of health-conscious consumers who prefer organic products over conventional products because of their highly processed methods, artificial ingredients, and their effects on babies' hormones and growth. Key players are seizing this trend to offer organic infant formulas and strengthen their market position. For instance, in September 2021, Bunge Loders Croklaan, the Netherlands plant-based lipids business of Bunge, a US-based food production company introduced Betapol Organic, the first certified organic OPO (Oleic-Palmitic-Oleic or SN-2 palmitate) on the Chinese and European markets. Betapol Organic is a certified organic OPO for infant milk formula which uses a natural component of human breast milk. Betapol Organic is an organic infant formula ingredient that helps increase bone mineral density, positively affects healthy gut bacteria, improves energy intake, reduces constipation, improves fine motor skills, reduces crying, and results in better sleep. In April 2020, Royal DSM, a Dutch chemicals company acquired Glycom A/S for $831 million. With this acquisition, DSM aims to develop prebiotics for infants based on Glycom’s human milk oligosaccharides (HMO) which are a group of carbohydrate structures found in human breast milk. DSM will also focus on developing and commercializing HMOs to fulfill consumer demands. Glycom A/S is a Danish biotechnology company supplying HMOs. North America was the largest region in the infant formula ingredients market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global infant formula ingredients market share during the forecast period. The regions covered in infant formula ingredients market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the infant formula ingredients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The infant formula ingredients market consists of sales of protein, linoleic acid, fat-soluble vitamins A, D, E, K, niacin, thiamine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The infant formula ingredients market research report is one of a series of new reports from The Business Research Company that provides infant formula ingredients market statistics, including infant formula ingredients industry global market size, regional shares, competitors with a infant formula ingredients market share, detailed infant formula ingredients market segments, infant formula ingredients market trends and opportunities, and any further data you may need to thrive in the infant formula ingredients industry. This infant formula ingredients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Care management solutions are a suite of services that patients can used to manage their chronic health conditions. They are used to provide a complete set of services and activities designed to assist people with chronic or complicated medical illnesses. The main types of components in care management solutions are software and services. The services refer to a comprehensive suite of services and activities that help patients with chronic or complex conditions manage their health. The care management solutions are delivered via on-premises and cloud-based methods that are used in several applications such as disease management, case management, and utilization management. It is employed in hospitals and clinics, accountable care organizations (ACOs), health insurance providers, and other end users. The global care management solutions market is segmented - 1) By Component: Software, Services 2) By Delivery Mode: On-premise, Cloud-based 3) By Application: Disease Management, Case Management, Utilization Management 4) By End User: Hospitals And Clinics, Accountable Care Organizations (ACOs), Health Insurance Providers, Other End-Users The global care management solutions market size grew from $14.14 billion in 2022 to $16.56 billion in 2023 at a compound annual growth rate (CAGR) of 17.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the care management solutions is expected to grow to $29.47 billion in 2027 at a CAGR of 15.5%. The increase in investment in digital healthcare is expected to propel the growth of the care management solutions market going forward. Digital healthcare prevents disease and lowers healthcare costs while helping patients monitor and manage chronic conditions. It can also tailor medicine for individual patients. A digital healthcare solution would allow users to share and receive files online via desktops, laptops, and mobile devices. For instance, according to the Healthcare Information and Management Systems Society, a US-based not-for-profit healthcare organization, in 2021, the financing for digital communication technology grew by 72% during the COVID-19 outbreak, and telemedicine alone received $4.3 billion in financing in 2020. The total amount invested in digital health has hit an all-time high of $26.5 billion. Therefore, the increasing investment in digital healthcare is driving the demand for the care management solutions market. Major players in the care management solutions market are Cerner Corporation, International Business Machines Corporation, Koninklijke Philips N.V., ZeOmega Infotech Private Limited, i2i Population Health, EPIC Systems Inc., Salesforce Inc., Pegasystems Inc., Mediware Information Systems, Allscripts Healthcare Solutions Inc., EXL Service Holdings, Exlservice Holdings Inc., Zeomega Inc., Health Catalyst Inc., Conduent Inc., Envolve Health, Trizetto Corporation, Healthsmart Holdings Inc., and Axispoint Health. Technological advancement is a key trend gaining popularity in the care management solution market. Major companies operating in the care management solutions sector are focused on developing new technological solutions to strengthen their position in the market. For instance, in October 2020, VirtualHealth, a US-based comprehensive care management platform, introduce HELIOS Essentials. HELIOS Essentials provides unprecedented configuration and potent AI-powered automations for specialist care providers and mid-size healthcare companies. It dismisses data silos, streamlines operations, uses less IT resources, and enables value-based, whole-person care. This launch represents another step forward for the company and the care management solutions market. In January 2021, Royal Philips, a US-based health technology company, acquired Capsule Technologies, Inc. for a deal amount of $635 million. Through this acquisition, Philips would expand its patient care management offering and look forward to participating strengths, adding a vendor-neutral medical device combination that further unlocks the ability of medical device data to improve patient monitoring and management. Capsule Technologies is a US-based company that provides medical device integration, clinical surveillance, and patient monitoring for hospitals. North America was the largest region in the care management solutions market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the care management solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the care management solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The care management solutions market includes revenues earned by entities by providing case and disease management and value-based services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced.It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The care management solutions market research report is one of a series of new reports from The Business Research Company that provides care management solutions market statistics, including care management solutions industry global market size, regional shares, competitors with a care management solutions market share, detailed care management solutions market segments, market trends and opportunities, and any further data you may need to thrive in the care management solutions industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Fetal and neonatal monitoring devices market are used to assess the fetal heart rate and contractions of the uterus during pregnancy and childbirth. The main equipment of fetal and neonatal monitoring devices and equipment are fetal and neonatal. Neonatal monitoring devices and equipment are used for the monitoring of various body parameters of the newborn. Portable or non-portable fetal and neonatal monitoring devices and equipment Fetal care equipment types are ultrasound devices, fetal dopplers, fetal MRI systems, fetal monitors, and fetal pulse oximeters. Neonatal care equipment types are infant warmers, incubators, convertible warmers and incubators, phototherapy equipment, respiratory devices, neonatal monitoring devices, and diagnostic imaging devices. The various end-users are hospitals, diagnostic centres, pediatric clinics, and ambulatory surgical centres. The global fetal and neonatal monitoring devices market is segmented - 1) By Equipment: Fetal, Neonatal 2) By End User: Hospitals, Diagnostic centers, Pediatric Clinics, Ambulatory Surgical Centers 3) By Portability: Portable, Non Portable 4) By Fetal Care Equipment Type: Ultrasound Devices, Fetal Dopplers, Fetal MRI Systems, Fetal Monitors, Fetal Pulse Oximeters 5) By Neonatal Care Equipment Type: Infant Warmers, Incubators, Convertible Warmers & Incubators, Phototherapy Equipment, Respiratory Devices, Neonatal Monitoring Devices, Diagnostic Imaging Devices The global fetal and neonatal monitoring devices market size will grow from $7.62 billion in 2022 to $8 billion in 2023 at a compound annual growth rate (CAGR) of 4.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of fetal and neonatal monitoring devices is expected to grow to $9.31 billion in 2027 at a CAGR of 3.9%. The increasing prevalence of preterm births and the low body weight of infants act as a factor driving the fetal and neonatal monitoring devices market growth. Preterm birth refers to the premature birth of a child before 37 weeks gestation period, which leads to poor health and growth, mental retardation, visual and hearing impairments, cerebral palsy, and others. According to World Health Organization (WHO), around 1 million babies die each year and preterm birth was found to be one of the top reasons for the deaths. According to the report by WHO, nearly 15 million babies are born preterm every year and this number is expected to have a continuous rise shortly. The increasing prevalence and need to reduce the infant mortality rates with improving healthcare conditions drives the fetal and neonatal monitoring devices market. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2021 the preterm birth rate in American women was 10.5%. Major players in the fetal and neonatal monitoring devices market are GE Healthcare, Fisher & Paykel Healthcare Limited, Philips Healthcare, Atom Medical Corporation, Natus Medical Incorporated, Analogic Corporation, Phoenix Medical Systems (P) Ltd., Becton Dickinson, Masimo Corporation, and Drägerwerk AG & Co. KGAA. The fetal and neonatal monitoring device market is restricted by stringent regulatory policies governing this market. The fetal and neonatal device manufacturers need to pass through several tests and requirements laid down by different regulatory bodies. Regulations like FDA's Center for Devices and Radiological Health (CDRH), NMPA regulations, EU directives lay down some stringent regulations for this equipment. The changes related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes lead to increased healthcare costs. For instance, according to a report by Ernst and Young, Fortune 500 companies are spending $7.8 billion to comply with GDPR. The GDPR is an EU law on the data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). Furthermore, the FDA is requesting more clinical data to support claims resulting in increased processing times of 510(k)s by over 55% over the last decade, thus delaying the operating cycle of manufacturers in this market. Fetal and neonatal monitoring device manufacturers are increasingly innovating and integrating technologies such as wireless technology with patient monitoring devices to efficiently diagnose and monitor fetuses and newborns. Wireless sensor technology such as biosensor monitoring devices, wireless fetal heart rate monitoring devices is multi-sensor systems implanted or embedded into the skin, consisting of a sensor that transmits data for real-time monitoring of a patient’s medical condition. For instance, the National Institute of Neurological Disorders and Stroke developed SARA, a scanning device that can detect fetal brain activity with the help of flashes of light transmitted through the mother's abdomen. Philips developed a new cordless fetal monitoring device that helps in ensuring the safety of the mother as well as the child without any inconvenience and risk. These technological innovations eliminate poor reception of observation and help caregivers in monitoring more efficiently. Hong Kong’s Department of Health, a regulatory body for fetal and neonatal monitoring devices of Hong Kong, sent a medical device safety alert to Guangzhou Sunray Medical Apparatus Co., Ltd., a medical device manufacturer, concerning its maternal and fetal monitor. The safety alert was sent as the Guangzhou Sunray maternal and fetal monitor was delivering inaccurate ultrasound-derived fetal heart rate recordings due to software-related issues. These devices impacted patients’ health with delayed intervention resulting in severe injury or death to the fetus. To reduce incidences associated with these devices MRHA sent a medical device safety alert to correct the device. Similarly, in January 2021, Medtronic PLC., received Class II recall notice from the Food and Drug administration for its Neonatal valves due to problematic design. The faulty device resulted in shunt malfunction in certain cases. Asia-Pacific was the largest region in the global fetal and neonatal monitoring devices market in 2022. North America was the second-largest region in the fetal and neonatal monitoring devices market report. The regions covered in the fetal and neonatal monitoring devices and equipment analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the fetal and neonatal monitoring devices market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The fetal and neonatal monitoring devices market consists of sales of instruments such as ultrasound devices, fetal dopplers, fetal MRI systems, fetal monitors, and fetal pulse oximeters. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The fetal and neonatal monitoring devices market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The fetal and neonatal monitoring devices market research report is one of a series of new reports from The Business Research Company that provides fetal and neonatal monitoring devices market statistics, including fetal and neonatal monitoring devices and equipment industry global market size, regional shares, competitors with a fetal and neonatal monitoring devices market share, detailed fetal and neonatal monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the fetal and neonatal monitoring devices and equipment industry. This fetal and neonatal monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Lactose-free infant formula are used for infants with lactose intolerance. Lactose-free infant formula is designed for babies having difficulty digesting lactose that naturally occurs in breast and cow’s milk. Infants with lactose intolerance may not completely digest the lactose in milk which can cause them health problems like gas, stomach rumbling, cramping, bloating, and diarrhea. The main types of lactose-free infant formula are milk infant formula and non-milk infant formula. Milk infant formula is made from cows' milk which resembles breast milk. The indications segment consists of starting formula, specialized formula and follow-on formula that are made according to the age of the baby. The application type consists of premature, babies with galactosemia, infants with cow’s milk protein allergies, and other applications. The distribution channel has supermarkets or hypermarkets, specialty stores, online retail stores and other distribution channels. The global lactose free infant formula market is segmented – 1) By Type: Milk Infant Formula, Non-Milk Infant Formula 2) By Indications: Starting Formula, Specialized Formula, Follow-On Formula 3) By Application: Premature, Babies With galactosemia, Infants With Cows Milk Protein Allergies, Other Applications 4) By Distribution Channel: Supermarkets/Hypermarkets, Specialist Stores, Online Retail Stores, Other Distribution Channels The global lactose-free infant formula market size grew from $14.91 billion in 2022 to $16.66 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of global lactose-free infant formula is expected to grow to $25.45 billion in 2027 at a CAGR of 11.2%. The rising incidences of lactose intolerance are expected to propel the growth of the lactose-free infant formula market. Lactose intolerance occurs when people cannot fully digest the lactose present in the milk leading to various health problems such as bloating, gas, and diarrhea. Lactose intolerant infants are required to take lactose-free infant formula to fulfill their nutrition requirements. For instance, according to an article published by The Times of India, an Indian daily newspaper and digital news media, as of May 2020, 60% of Indians were suffering from milk intolerance. Therefore, the rising incidence of lactose intolerance among infants is driving the lactose-free infant formula market. Major players in the lactose-free infant formula market are Nestle S.A, Valio Ltd., Danone S.A, Abbott, Silverson, Gimme the Good Stuff, Mead Johnson & Company LLC, Gerber, HiPP International, Vermont Organics, Perrigo Company plc, Earth's Best, Nutricia, Dana Dairy Group, and Nurture Inc. Product innovations are a key trend gaining popularity in the lactose-free infant formula market. Product innovation is the creation or introduction of a new good or launching the improved version of a previous good. For instance, in September 2020, Else, an Israel-based start-up, announced the launch of plant-based milk for toddlers. The product is expected to be a game-changer for children having lactose intolerance and other food sensitivities. It offers 30% of a child’s daily calcium requirement, five grams of protein, and three grams of sugar through one serving. The USDA-certified powdered organic formula features buckwheat flour, almond butter, tapioca, and 20 other vitamins and minerals. In September 2021, Primavera Capital Group, a Chinese investment firm acquired Mead Johnson’s business in China from Reckitt Benckiser Group for an undisclosed amount. The acquisition strengthens Primavera Capital Group's objective to enhance its growth prospects and position in China's large infant nutrition market including innovation, operational improvement, channel optimization, and digital transformation. Mead Johnson is a US-based infant and child nutrition company that provides lactose-free infant formula. Western Europe was the largest region in the lactose-free infant formula market in 2022. The regions covered in the lactose-free infant formula market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the lactose-free infant formula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The lactose-free infant formula market consists of sales of skimmed milk, plant-based soy protein. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this lactose-free infant formula market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The lactose-free infant formula market research report is one of a series of new reports from The Business Research Company that provides lactose-free infant formula market statistics, including lactose-free infant formula industry global market size, regional shares, competitors with a lactose-free infant formula market share, detailed lactose-free infant formula market segments, market trends and opportunities, and any further data you may need to thrive in the lactose-free infant formula industry. This lactose-free infant formula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Healthcare Interoperability system refers to the exchange of healthcare information between two or more systems. Healthcare interoperability enables seamless data sharing across healthcare organizations with the patient’s consent. Electronic health records (EHRs) along with health information exchange (HIE) services must be optimized and adopted by every healthcare firm to implement interoperability functionalities. Interoperability achievement depends on five key components namely, privacy and security, standards, rules of engagement, adoption & optimization, and financial & clinical incentives. The main types in the healthcare interoperability solutions market are software solutions and services. The services market in the healthcare interoperability solutions consists of sales of services by entities (organizations, sole traders, and partnerships) that are used for patient care and safety. The software solutions used in healthcare interoperability solutions include EHR interoperability solutions, Lab system solutions, imaging system solutions, healthcare information exchange solutions, enterprise solutions, and other healthcare solutions. The healthcare interoperability solution market operates at the foundation level, structural level, and semantic level. Healthcare interoperability solutions are used by healthcare providers, healthcare payers, and pharmacies. The global healthcare interoprability solutions market is segmented - 1) By Type: Software Solutions, Services 2) By Software Solutions: Eletronic Health Record (EHR) Interoperability Solutions, Lab System Interoperability Solutions, Imaging System Interoperability Solutions, Healthcare Information Exchange Interoperability Solutions, Enterprise Interoperability Solutions, Other Healthcare Interoperability Solutions 3) By Level of Interoperability: Foundational Interoperability, Structural Interoperability, Semantic Interoperability 4) By End User: Healthcare Providers, Healthcare Payers, Pharmacies The global healthcare interoperability solutions market size will grow from $3.82 billion in 2022 to $4.3 billion in 2023 at a compound annual growth rate (CAGR) of 12.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the healthcare interoperability solutions is expected to grow to $7.05 billion in 2027 at a CAGR of 13.2%. The government initiatives to enhance patient care and safety are expected to propel the growth of the healthcare interoperability solutions market over the coming years. The shortcoming in the healthcare system is arising due to its increasing demand in public leading to Covid -19 pandemic. Government authorities across the globe such as the Canter for Medicare & Medicaid Services (CMS) have set the goal of increasing healthcare availability by implementing advanced technologies to better treat the patients. For instance, in May 2020, CMS Interoperability and Patient Access Final Rule is published by CMS. The rule is promoting the policies that enable advanced interoperability and access to health information for all stakeholders. Major players in the healthcare interoperability solutions market are Cerner Corporation, Epic Systems Corporation, Koninklijke Philips N.V., ViSolve Inc., Jitterbit Inc., Quality Systems Inc., Orion Health Group Limited, Infor Inc., Allscripts Healthcare Solutions Inc., InterSystems Corporation, OSP, Interfaceware Inc., Virtusa Corp, Summit Healthcare Services Inc., Mphrx Inc., WIPRO Ltd., Emids Technologies Inc., Nalashaa Healthcare, and Deevita LLC. The increasing investments in the healthcare sector of emerging economies is a key trend gaining popularity in the healthcare interoperability solutions market. Due to the emergence of Covid, the global healthcare industry is growing tremendously leading to the increasing need for resources and attention. During the pandemic situation, Fast Healthcare Interoperability Resources (FHIR) got more attention as it uses the internet to access healthcare data. Emerging countries moving towards eHealth are adopting interoperability solutions as their first step towards digitization. The entrenched and legacy health systems are driving investments in digital health models from a wide range of economies globally. In September 2021, an America-based health information technology solution provider expanded its investment in the i.s.h.med electronic health record (EHR). i.s.h.med is the hospital information system that is integrated with the SAP solutions. Cerner’s this investment leads to its strong position in healthcare digitization. In February 2020, Symplr, an American-based company specializing in healthcare governance, risk management, and compliance (GRC) software as a service (SaaS) platform acquired The Patient Safety Company (TPSC) for an undisclosed amount. Through this acquisition, Symplr will be able to include patient safety and incident tracking and reporting portfolios in its end-to-end GRC SaaS solutions. The Patient Safety Company (TPSC) is a Netherland-based ICT solution provider in the healthcare industry. North America was the largest region in the healthcare interoperability solutions market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare interoperability solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the healthcare interoperability solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The healthcare interoperability market includes revenues earned by entities by providing DevOps services, security as a service, identity and access management services, data security services, cloud infrastructure security service. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The healthcare interoperability solutions market research report is one of a series of new reports from The Business Research Company that provides healthcare interoperability solutions market statistics, including healthcare interoperability solutions industry global market size, regional shares, competitors with a healthcare interoperability solutions market share, detailed healthcare interoperability solutions market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare interoperability solutions industry. This healthcare interoperability solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Patient monitoring devices are machines that are used to constantly monitor patients through various vital signs and warning systems to detect and record changes in patient health conditions. The main types of patient monitoring devices market are fetal and neonatal monitoring devices, weight monitoring and body temperature monitoring devices and equipment, vital parameter monitoring devices and equipment, and remote patient monitoring devices and equipment. Fetal and neonatal monitoring devices measure the heart rate and rhythm of the baby (fetus). This lets the healthcare providers see how the baby is doing. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The end-users are hospitals and clinics, diagnostic laboratories, and others. The global patient monitoring devices market is segmented - 1) By Type: Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables Subsegments Covered: Fetal Monitoring Devices, Neonatal Monitoring Devices, Temperature Monitoring Devices, Weight Monitoring Devices, Cardiac Monitoring Devices, Neuromonitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Multiparameter Monitoring Devices, Cardiac Monitors, Respiratory Monitors, Hematological Monitors, Vital Parameter Monitors And Other End Users The global patient monitoring devices market size will grow from $23.46 billion in 2022 to $25.53 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global patient monitoring devices is expected to grow to $34.5 billion in 2027 at a CAGR of 7.8%. The demand for monitoring devices is likely to increase due to the shortage of professionals in the healthcare services industry. According to a report by Mercer, the US requires 2.3 million new healthcare workers by 2025; this includes nurses, physicians, lab technicians, and various other healthcare personnel. This shortage is likely to drive the demand for monitoring systems as these devices allow medical professionals to track multiple patients remotely. This is expected to drive the growth of the patient monitoring devices market in the forecast period. Major companies in the patient monitoring devices market include General Electric Company, Koninklijke Philips N.V., Draegerwerk AG, Cardinal Health, Inc., Masimo, Stryker Corporation, Medtronic Inc., Edwards Lifesciences, Flex Ltd., and Nihon Kohden Corporation. Awareness of diseases is low in many countries across the globe, and this affected the demand for patient monitoring devices in the historic period. For instance, a study conducted by the Indian Council of Medical Research (ICMR) on 213 million people found that only 43.2% are aware of the chronic disease diabetes. This lack of disease awareness limited the diagnosis and treatment pool, thereby restricting market growth for patient monitoring devices. Patient monitoring device manufacturers are offering customized MPMs to cater to the growing patient pool. MPMs monitor different health parameters corresponding to patients’ health conditions. For instance, Infinium Medical’s Omni series monitors are preconfigured with ECG, oxygen saturation, non-invasive blood pressure, and temperature trackers. More advanced health measures such as invasive blood pressure, cardiac output, and anaesthetic agent measurement can be added to this device when needed. Custom MPM is predominantly beneficial for tracking the health status of critically ill patients. Asia-Pacific was the largest region in the global patient monitoring devices market in 2022. North America was the second-largest region in the global patient monitoring devices market share. The regions covered in the patient monitoring devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the patient monitoring devices market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The patient monitoring devices market consist of sales of instruments such as blood pressure cuffs, glucometers, pulse oximeter, ECG + stethoscope, wearables (activity trackers and continuous monitoring), and thermometers for patient monitoring. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The patient monitoring devices market research report is one of a series of new reports from The Business Research Company that provides patient monitoring devices market statistics, including patient monitoring devices industry global market size, regional shares, competitors with a patient monitoring devices market share, detailed patient monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the patient monitoring devices industry. This patient monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Home healthcare refers to a set of activities conducted to keep the home healthcare equipment in working condition. Home healthcare is supportive care provided by any professional caregiver in their respective homes where the patient is staying. It is a cost-effective way to deliver quality care at patients’ homes. Home healthcare is used to assist individuals in improving their health function by providing initial treatment and avoiding hospitalization. The main types of equipment in home healthcare are therapeutic, diagnostic, and mobility care. Therapeutic equipment refers to a set of activities conducted to keep it in working condition. The therapeutic equipment includes home respiratory therapy, insulin delivery devices, IV pumps, and others. The different indications include cardiovascular disorders & hypertension, diabetes, respiratory diseases, pregnancy, cancer, wound care, and others, and involve various services such as rehabilitation services, respiratory therapy services, infusion therapy services, and others. The global home healthcare market is segmented - 1) By Equipment: Therapeutic, Diagnostic, Mobility Care 2) By Services: Rehabilitation Services, Respiratory Therapy Services, Infusion Therapy Services, Other Services 3) By Indication: Cardiovascular Disorders & Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Cancer, Wound Care, Other Indications The global home healthcare market size grew from $308 billion in 2022 to $337.18 billion in 2023 at a compound annual growth rate (CAGR) of 9.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the home healthcare market is expected to grow to $479.99 billion in 2027 at a CAGR of 9.2%. The rapid increase in the aging population is significantly driving the growth of the home healthcare market going forward. The increase in the aging population will boost the demand for healthcare as the aged people are more prone to chronic diseases, which is a favorable factor to the home healthcare market, and increases the overall reach of various home health services. This will reduce the unnecessary visits time involved in traveling, hospital admission, and others. For instance, in 2020, according to the United Nations Organisations, a US-based intergovernmental organization, 727 million persons that were aged above 65 years , which will increase to 1.5 billionpeople by 2050. Therefore, the increase in the aging population is driving the growth of the home healthcare market. Major players in the home healthcare market are Fresenius SE & Co. KGaA, F. Hoffmann-La Roche AG, Resmed Inc., American Well, Apple Inc., CVS Health, Humana Inc., LHC Group Inc., Kindred Healthcare, Honor Home Care, Zorgers, Grand World Elder Care, and MediCar. Technological advancements have emerged as a key trend gaining popularity in the home healthcare market. Companies operating in the home healthcare market are adopting new technologies to reinforce their position in the market. For instance, in August 2020, American Homecare Health Services (AHHS), a US-based home health provider, launched telehealth and remote patient monitoring program. The program is launched in partnership with health recovery solutions. The new offering would be used to identify COVID-19 patients through their recorded symptoms and vital signs. In November 2021, Addus Homecare, a US-based company that provides home healthcare services acquired Armada hospice for a deal amount of $29 million. This acquisition helps Addus Homecare in creating multiple markets in various levels of home care services. Armada Hospice is a US-based company that provides hospital and health care services. North America was the largest region in the home healthcare market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the home healthcare market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the home healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The home healthcare market includes revenues earned by entities by physical, occupational, and/or speech therapy, medical social services, care from home health aides, and homemaker or basic assistance care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The home healthcare market research report is one of a series of new reports from The Business Research Company that provides home healthcare market statistics, including home healthcare industry global market size, regional shares, competitors with a home healthcare market share, detailed home healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the home healthcare industry. This home healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diagnostic devices (or) equipment market consists of sales of diagnostic equipment and related services by entities (organizations, sole traders, and partnerships) that are used to identify the nature or cause of a certain phenomenon, usually related to a medical condition. Some of the devices include magnetic resonance imaging apparatuses, temperature sensors or pacemakers. The main types of diagnostic devices or equipment are x-rayed systems, ultrasound systems, computed tomography (CT) scanners, magnetic resonance imaging systems, cardiovascular monitoring and diagnostic devices, and nuclear imaging devices. X-rays refer to a type of electromagnetic radiation, just like visible light. The mobility is stationary and mobile and is used in hospitals and diagnostic imaging centers. The global diagnostic equipment market size is expected to grow from $43.81 billion in 2021 to $47.74 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The global diagnostic equipment market size is expected to grow to $59.46 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. An increase in the geriatric population is expected to propel the growth of the diagnostic devices market going forward. Older people are likely to suffer from diseases such as diabetes, cancer, and arthritis, among others, which would increase the demand for diagnostic devices. For instance, in 2020, according to the United Nations, a US-based intergovernmental organization, there are approximately 727 million persons are aged 65 years and above worldwide, and expected to reach approximately 1.5 billion persons by 2050. Therefore, the increase in the geriatric population is driving the growth of the diagnostic devices market.  The emergence of routine diagnostic kits is a key trend gaining popularity in the diagnostic devices market. Companies operating in the market are focusing on developing diagnostic kits to gain market coverage. For instance, in March 2022, Mylab Discovery Solutions, an India-based healthcare company, is set to launch an entire range of routine diagnostic kits and devices in conventional and point-of-care formats. Immunology, Biochemistry, and Haematology are the three main market sub-segments represented by the devices and kits included in them.  In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, acquired Luminex Corporation for a deal amount of $1.8 billion. Through the acquisition, DiaSorin would gain access to Luminex’s multiplexing technology and a portfolio that would strengthen its existing offering while expanding the group's presence in the United States. Further, this agreement would give the life science sector access to Luminex's applications, promoting academic and scientific research, improving collaboration with biopharma businesses, and boosting access to clinical multiplexing assays for upcoming Value-Based Care initiatives. Luminex Corporation is a US-based biotechnology company that manufactures medical diagnostic devices. Major players in the diagnostic equipment market include Philips Healthcare, Hitachi Medical Systems, Fujifilm Holdings, Siemens Healthcare, and GE Healthcare. The regions covered in global diagnostic equipment market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the diagnostic devices or equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global diagnostic equipment market is segmented - 1) By Type: X-Ray Systems, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging Systems, Cardiovascular Monitoring and Diagnostic Devices, and Nuclear Imaging Device 2) By Mobility: Stationary, Mobile 3) By End User: Hospitals, Diagnostic imaging centres